T. Minami et al., ROLE OF METALLOTHIONEIN IN 4-AMINOPYRAZOLO[3,4-D]PYRIMIDINE-ADMINISTERED MOUSE PANCREAS, Biological & pharmaceutical bulletin, 16(11), 1993, pp. 1108-1110
Pancreatic metallothionein (MT) and zinc levels were measured after th
e administration of 4-aminopyrazolo(3,4-d)pyrimidine (4APP) to mice to
determine the role of pancreatic MT. 4APP was found to increase the p
ancreatic MT level dose-dependently; the pancreatic MT level in mice a
dministered 175 mg/kg of 4APP was 3.9 fold higher than that in control
mice. When 40 mg/kg or less of 4APP was administered, the zinc concen
tration of the pancreatic cytosol fraction did not differ from that in
control mice, while after 175 mg/kg of 4APP it was 1.7-fold higher. T
here was no difference in plasma glucose and insulin levels between th
e controls and mice administered 175 mg/kg of 4APP, although the plasm
a alpha-amylase activity was reduced in the latter. Moreover, a linear
negative relationship was observed between pancreatic MT level and pl
asma alpha-amylase activity (r = - 0.795, p < 0.01). These findings su
ggest that pancreatic MT is affected by the disruption of the exocrine
function in 4APP-administered mouse pancreas.